focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Regulatory News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,134.00
Bid: 12,132.00
Ask: 12,134.00
Change: -38.00 (-0.31%)
Spread: 2.00 (0.016%)
Open: 12,180.00
High: 12,198.00
Low: 12,076.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

22 Jul 2020 15:00

RNS Number : 7684T
AstraZeneca PLC
22 July 2020
 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

AstraZeneca PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

Other (please specify):

3. Details of person subject to the notification obligation

Name

Wellington Management Company LLP

City and country of registered office (if applicable)

Boston, USA

4. Full name of shareholder(s)  (if different from 3)

Name

Bank of New York (Nominees) Ltd

BBH ISL NOMINEES LTD

BNY (OCS) Nominees Limited

BNY Mellon Nominees Limited

GOLDMAN SACHS INTERNATIONAL

HSBC Global Custody Nominee (UK) Limited

Japan Trustee Services Bank Ltd.

JP Morgan Chase Nominees Limited

Mellon Nominees (UK) Ltd.

Nortrust Nominees Limited

ROY Nominees Limited

State Street Nominees Limited

VIDACOS NOMINEES LIMITED

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached:

20/07/2020

6. Date on which issuer notified (DD/MM/YYYY):

21/07/2020

7. Total positions of person(s) subject to the notification obligation:

% of voting rights attached to shares

(total of 8.A)

% of voting rights through financial instruments

(total of 8.B.1 + 8.B.2)

Total of both in %

(8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

2.95%

2.01%

4.96%

1,312,271,081

Position of previous notification (if applicable)

2.97%

2.04%

5.01%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: Voting rights attached to shares

Class/type of shares ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0009895292 Ordinary Shares

38,723,069

2.95%

SUBTOTAL 8.A

38,723,069

2.95%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Depository Receipt

51,934,556 Depository Receipt shares or 25,967,241 votes on a converted basis

1.98%

SUBTOTAL 8.B.1

25,967,241

1.98%

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Physical or cash settlement

Number of voting rights

% of voting rights

Equity Swap

29/01/2021

03/02/2020to29/01/2021

Cash settlement

183,970 Equity Swap shares or 91,985 votes on a converted basis

0.01%

Equity Swap

31/12/2020

05/12/2019to31/12/2020

Cash settlement

140,896 Equity Swap shares or 70,448 votes on a converted basis

0.01%

Equity Swap

30/04/2021

04/05/2020to30/04/2021

Cash settlement

57,837 Equity Swap shares or 28,918 votes on a converted basis

0.00%

Equity Swap

30/06/2021

02/07/2020to30/06/2021

Cash settlement

56,143 Equity Swap shares or 28,071 votes on a converted basis

0.00%

Equity Swap

31/03/2021

02/04/2020to31/03/2021

Cash settlement

55,558 Equity Swap shares or 27,779 votes on a converted basis

0.00%

Equity Swap

31/08/2020

08/08/2019to31/08/2020

Cash settlement

42,723 Equity Swap shares or 21,361 votes on a converted basis

0.00%

Equity Swap

15/05/2023

09/08/2018to15/05/2023

Cash settlement

19,846 Equity Swap shares or 19,846 votes on a converted basis

0.00%

Equity Swap

15/05/2023

20/02/2019to15/05/2023

Cash settlement

35,896 Equity Swap shares or 17,948 votes on a converted basis

0.00%

Equity Swap

15/05/2023

02/03/2018to15/05/2023

Cash settlement

11,419 Equity Swap shares or 11,419 votes on a converted basis

0.00%

Equity Swap

15/05/2023

10/10/2017to15/05/2023

Cash settlement

8,928 Equity Swap shares or 8,928 votes on a converted basis

0.00%

Equity Swap

22/05/2023

08/10/2018to22/05/2023

Cash settlement

7,796 Equity Swap shares or 7,796 votes on a converted basis

0.00%

Index Future

20/07/2020

01/01/1900to20/07/2020

Cash settlement

1,394 Index Future shares or 7,186 votes on a converted basis

0.00%

Equity Swap

22/05/2023

05/10/2018to22/05/2023

Cash settlement

6,487 Equity Swap shares or 6,487 votes on a converted basis

0.00%

Equity Swap

15/05/2023

09/02/2018to15/05/2023

Cash settlement

6,300 Equity Swap shares or 6,300 votes on a converted basis

0.00%

Equity Swap

22/05/2023

15/07/2019to22/05/2023

Cash settlement

6,212 Equity Swap shares or 6,212 votes on a converted basis

0.00%

Equity Swap

22/05/2023

15/06/2020to22/05/2023

Cash settlement

5,919 Equity Swap shares or 5,919 votes on a converted basis

0.00%

Equity Swap

22/05/2023

23/08/2019to22/05/2023

Cash settlement

4,413 Equity Swap shares or 4,413 votes on a converted basis

0.00%

Equity Swap

05/05/2023

03/06/2020to05/05/2023

Cash settlement

3,967 Equity Swap shares or 3,967 votes on a converted basis

0.00%

Equity Swap

15/05/2023

02/02/2018to15/05/2023

Cash settlement

3,782 Equity Swap shares or 3,782 votes on a converted basis

0.00%

Equity Swap

22/05/2023

03/07/2018to22/05/2023

Cash settlement

3,496 Equity Swap shares or 3,496 votes on a converted basis

0.00%

Equity Swap

22/05/2023

06/01/2020to22/05/2023

Cash settlement

3,382 Equity Swap shares or 3,382 votes on a converted basis

0.00%

Equity Swap

22/05/2023

08/01/2019to22/05/2023

Cash settlement

3,207 Equity Swap shares or 3,207 votes on a converted basis

0.00%

Equity Swap

22/05/2023

05/04/2018to22/05/2023

Cash settlement

2,982 Equity Swap shares or 2,982 votes on a converted basis

0.00%

Equity Swap

15/05/2023

02/07/2018to15/05/2023

Cash settlement

2,827 Equity Swap shares or 2,827 votes on a converted basis

0.00%

Equity Swap

15/05/2023

23/10/2017to15/05/2023

Cash settlement

2,779 Equity Swap shares or 2,779 votes on a converted basis

0.00%

Equity Swap

05/05/2023

20/08/2019to05/05/2023

Cash settlement

5,393 Equity Swap shares or 2,696 votes on a converted basis

0.00%

Equity Swap

22/05/2023

02/06/2020to22/05/2023

Cash settlement

4,154 Equity Swap shares or 2,077 votes on a converted basis

0.00%

Equity Swap

15/05/2023

28/05/2020to15/05/2023

Cash settlement

3,963 Equity Swap shares or 1,981 votes on a converted basis

0.00%

Equity Swap

22/05/2023

10/07/2020to22/05/2023

Cash settlement

1,830 Equity Swap shares or 1,830 votes on a converted basis

0.00%

Equity Swap

15/05/2023

16/07/2018to15/05/2023

Cash settlement

1,776 Equity Swap shares or 1,776 votes on a converted basis

0.00%

Equity Swap

22/05/2023

14/04/2020to22/05/2023

Cash settlement

3,326 Equity Swap shares or 1,663 votes on a converted basis

0.00%

Equity Swap

22/05/2023

05/06/2020to22/05/2023

Cash settlement

1,570 Equity Swap shares or 1,570 votes on a converted basis

0.00%

Equity Swap

15/05/2023

26/06/2020to15/05/2023

Cash settlement

2,796 Equity Swap shares or 1,398 votes on a converted basis

0.00%

Equity Swap

15/05/2023

11/06/2018to15/05/2023

Cash settlement

1,367 Equity Swap shares or 1,367 votes on a converted basis

0.00%

Equity Swap

05/05/2023

31/07/2019to05/05/2023

Cash settlement

2,654 Equity Swap shares or 1,327 votes on a converted basis

0.00%

Equity Swap

05/05/2023

12/08/2019to05/05/2023

Cash settlement

1,926 Equity Swap shares or 963 votes on a converted basis

0.00%

Equity Swap

22/05/2023

08/06/2020to22/05/2023

Cash settlement

1,841 Equity Swap shares or 920 votes on a converted basis

0.00%

Equity Swap

15/05/2023

08/10/2019to15/05/2023

Cash settlement

1,721 Equity Swap shares or 860 votes on a converted basis

0.00%

Equity Swap

22/05/2023

20/01/2020to22/05/2023

Cash settlement

829 Equity Swap shares or 829 votes on a converted basis

0.00%

Equity Swap

15/05/2023

14/06/2019to15/05/2023

Cash settlement

1,593 Equity Swap shares or 796 votes on a converted basis

0.00%

Equity Swap

22/05/2023

06/07/2020to22/05/2023

Cash settlement

1,587 Equity Swap shares or 793 votes on a converted basis

0.00%

Equity Swap

05/05/2023

14/07/2020to05/05/2023

Cash settlement

1,504 Equity Swap shares or 752 votes on a converted basis

0.00%

Equity Swap

22/05/2023

01/11/2019to22/05/2023

Cash settlement

1,308 Equity Swap shares or 654 votes on a converted basis

0.00%

Equity Swap

22/05/2023

13/05/2020to22/05/2023

Cash settlement

1,308 Equity Swap shares or 654 votes on a converted basis

0.00%

Equity Swap

15/05/2023

16/05/2019to15/05/2023

Cash settlement

1,290 Equity Swap shares or 645 votes on a converted basis

0.00%

Equity Swap

15/05/2023

27/07/2018to15/05/2023

Cash settlement

600 Equity Swap shares or 600 votes on a converted basis

0.00%

Equity Swap

15/05/2023

29/06/2020to15/05/2023

Cash settlement

1,128 Equity Swap shares or 564 votes on a converted basis

0.00%

Equity Swap

15/05/2023

31/03/2020to15/05/2023

Cash settlement

1,052 Equity Swap shares or 526 votes on a converted basis

0.00%

Equity Swap

05/05/2023

03/02/2020to05/05/2023

Cash settlement

1,037 Equity Swap shares or 518 votes on a converted basis

0.00%

Equity Swap

22/05/2023

06/01/2020to22/05/2023

Cash settlement

516 Equity Swap shares or 516 votes on a converted basis

0.00%

Equity Swap

22/05/2023

08/10/2018to22/05/2023

Cash settlement

486 Equity Swap shares or 486 votes on a converted basis

0.00%

Equity Swap

05/05/2023

15/08/2019to05/05/2023

Cash settlement

841 Equity Swap shares or 420 votes on a converted basis

0.00%

Equity Swap

05/05/2023

13/08/2019to05/05/2023

Cash settlement

834 Equity Swap shares or 417 votes on a converted basis

0.00%

Equity Swap

05/05/2023

02/08/2019to05/05/2023

Cash settlement

818 Equity Swap shares or 409 votes on a converted basis

0.00%

Equity Swap

15/05/2023

26/07/2019to15/05/2023

Cash settlement

647 Equity Swap shares or 323 votes on a converted basis

0.00%

Equity Swap

22/05/2023

03/10/2019to22/05/2023

Cash settlement

162 Equity Swap shares or 162 votes on a converted basis

0.00%

Equity Swap

22/05/2023

21/04/2020to22/05/2023

Cash settlement

131 Equity Swap shares or 131 votes on a converted basis

0.00%

Equity Swap

05/05/2023

13/09/2019to05/05/2023

Cash settlement

40 Equity Swap shares or 40 votes on a converted basis

0.00%

SUBTOTAL 8.B.2

428,101

0.03%

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Wellington Management Company LLP

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information:

 

 

Place of completion

London

Date of completion

21/07/2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLGCGDRUUDDGGD
Date   Source Headline
30th Sep 20214:00 pmRNSDirector/PDMR Shareholding
29th Sep 20217:00 amRNSAstraZeneca to fully acquire Caelum Biosciences
28th Sep 20217:00 amRNSSaphnelo approved in Japan for SLE
24th Sep 20217:00 amRNSLynparza PROpel trial meets primary endpoint
23rd Sep 20217:00 amRNSBoard Committee Change
23rd Sep 20217:00 amRNSNew Sustainability Committee of the Board
21st Sep 20217:00 amRNSAstraZeneca $360m Irish manufacturing investment
20th Sep 20217:00 amRNSEnhertu reduced risk of disease progression by 72%
9th Sep 20214:00 pmRNSImfinzi improves survival in NSCLC in POSEIDON
9th Sep 20217:00 amRNSPT027 PhIII asthma trials met primary endpoints
3rd Sep 20217:00 amRNSUltomiris approved in EU for children with PNH
1st Sep 20213:00 pmRNSTotal Voting Rights
26th Aug 20217:05 amRNSForxiga approved in Japan for CKD
26th Aug 20217:00 amRNSALXN1840 Wilson Phase III met primary endpoint
20th Aug 20217:05 amRNSUpdate on Ultomiris Phase III ALS trial
20th Aug 20217:00 amRNSAZD7442 prophylaxis trial met primary endpoint
16th Aug 20213:00 pmRNSDirector/PDMR Shareholding
11th Aug 20212:35 pmRNSUpdate on US review of roxadustat
9th Aug 20217:05 amRNSForxiga approved in the EU for CKD
9th Aug 20217:00 amRNSEnhertu head-to-head trial meets primary endpoint
2nd Aug 20213:00 pmRNSTotal Voting Rights
2nd Aug 20217:00 amRNSSaphnelo approved in the US for SLE
29th Jul 20217:00 amRNSAZN: H1 2021 Results
26th Jul 20217:00 amRNSUltomiris recommended in EU for children with PNH
22nd Jul 20217:00 amRNSDirectorate Change
21st Jul 20213:56 pmRNSDirector/PDMR Shareholding
21st Jul 20213:45 pmRNSTotal Voting Rights
21st Jul 20211:45 pmRNSAcquisition of Alexion completed
19th Jul 20217:00 amRNSImfinzi approved in China for extensive-stage SCLC
16th Jul 20217:00 amRNSStatus on US FDA Advisory Committee for roxadustat
15th Jul 20215:30 pmRNSAstraZeneca
14th Jul 20217:08 amRNSAstraZeneca-Alexion transaction cleared in the UK
8th Jul 20217:00 amRNSTezepelumab granted FDA Priority Review for asthma
6th Jul 20217:00 amRNSAstraZeneca-Alexion transaction cleared in the EU
1st Jul 20213:00 pmRNSTotal Voting Rights
28th Jun 20217:05 amRNSForxiga recommended in EU for patients with CKD
28th Jun 20217:00 amRNSNirsevimab PhII/III trial confirms safety profile
24th Jun 20217:00 amRNSLynparza approved in China for prostate cancer
23rd Jun 20217:00 amRNSOrpathys approved in China for lung cancer
22nd Jun 20217:00 amRNSKoselugo approved in the EU for children with NF1
15th Jun 20217:00 amRNSUpdate on AZD7442 STORM CHASER trial
10th Jun 202111:32 amRNSStabilisation Notice
7th Jun 20217:00 amRNSCalquence head-to-head results versus ibrutinib
4th Jun 20217:05 amRNSLynparza reduced recurrence risk in breast cancer
4th Jun 20217:00 amRNSAstraZeneca appoints new Chief Financial Officer
2nd Jun 20217:00 amRNSPublication of Final Terms
1st Jun 20213:01 pmRNSBlock listing Interim Review
1st Jun 20213:00 pmRNSTotal Voting Rights
28th May 20217:00 amRNSTagrisso approved in EU in early lung cancer
27th May 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.